A detailed history of Adell Harriman & Carpenter Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Adell Harriman & Carpenter Inc holds 11,659 shares of LLY stock, worth $9.28 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
11,659
Previous 9,749 19.59%
Holding current value
$9.28 Million
Previous $8.83 Billion 17.02%
% of portfolio
0.75%
Previous 0.68%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $1.47 Million - $1.83 Million
1,910 Added 19.59%
11,659 $10.3 Billion
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $1.89 Million - $2.38 Million
2,613 Added 36.62%
9,749 $8.83 Billion
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $935,676 - $1.25 Million
1,580 Added 28.44%
7,136 $5.55 Billion
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $1.35 Million - $1.59 Million
2,574 Added 86.32%
5,556 $3.24 Billion
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $361,670 - $498,617
832 Added 38.7%
2,982 $1.6 Billion
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $506,117 - $676,738
1,443 Added 204.1%
2,150 $992 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $46,594 - $54,723
-150 Reduced 17.5%
707 $243 Million
Q4 2022

Feb 03, 2023

SELL
$321.55 - $374.67 $64,310 - $74,934
-200 Reduced 18.92%
857 $314 Million
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $59,296 - $67,574
200 Added 23.34%
1,057 $342 Million
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $7,246 - $8,509
-26 Reduced 2.94%
857 $277,000
Q1 2022

Apr 29, 2022

SELL
$234.69 - $291.66 $283,974 - $352,908
-1,210 Reduced 57.81%
883 $252,000
Q4 2021

Feb 16, 2022

SELL
$224.85 - $279.04 $1.23 Million - $1.52 Million
-5,463 Reduced 72.3%
2,093 $578,000
Q3 2021

Nov 05, 2021

BUY
$221.6 - $272.71 $1.67 Million - $2.06 Million
7,556 New
7,556 $1.75 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Adell Harriman & Carpenter Inc Portfolio

Follow Adell Harriman & Carpenter Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.